AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29564973 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% 1RM (G80)
Number of subjects: 30
Study 29564973 — intervention group
Group type: COMPARATOR
Intervention: All groups (G20, G40, G60, G80)
Number of subjects: 30
Study 25900900 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasternal block with pharmacologic analgesia (group P)
Number of subjects: 81
Study 25900900 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic analgesia alone (group C)
Number of subjects: 81
Study 24450342 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 60
Study 24450342 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 60
Study 22985567 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Lizer group (daily linearly polarized near-infrared irradiation)
Number of subjects: 84
Study 22985567 — intervention group
Group type: EXPERIMENTAL
Intervention: S+P group (daily Super Lizer and aerothermotherapy)
Number of subjects: 84
Study 22985567 — intervention group
Group type: COMPARATOR
Intervention: Control group (drug therapy and shoulder exercise)
Number of subjects: 84
Study 20496181 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity functional weight-bearing exercise programme
Number of subjects: 191
Study 20496181 — intervention group
Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 191
Study 18353503 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ondansetron (0.15 mg/kg; maximum 4 mg)
Number of subjects: 255
Study 18353503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 15877944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 11
Study 15877944 — intervention group
Group type: COMPARATOR
Intervention: External Beam Radiation Therapy (EBRT)
Number of subjects: 11
Study 12206945 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion at 25 deg s(‐1)
Number of subjects: 18
Study 12206945 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion at 5 deg s(‐1)
Number of subjects: 18
Study 12206945 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion at both velocities
Number of subjects: 18
Study 9696240 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 386
Study 9696240 — intervention group
Group type: COMPARATOR
Intervention: No medication or other types of analgesics
Number of subjects: 386
Study 8135395 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible, spiral‐wound tracheal tube (TT)
Number of subjects: 40
Study 8135395 — intervention group
Group type: COMPARATOR
Intervention: Standard, preformed tracheal tube (TT)
Number of subjects: 40
Study 2672485 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram (variable rate infusion)
Number of subjects: 25
Study 2672485 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation
Number of subjects: 25
Study 409101 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH
Number of subjects: 15
Study 30291545 — intervention group
Group type: COMPARATOR
Intervention: 0.4% fucoidan (D5)
Number of subjects: 6
Study 30291545 — intervention group
Group type: COMPARATOR
Intervention: ≥0.2% fucoidan (D4, D5)
Number of subjects: 6
Study 30291545 — intervention group
Group type: COMPARATOR
Intervention: 0.2% fucoidan (D4)
Number of subjects: 6
Study 30058979 — intervention group
Group type: EXPERIMENTAL
Intervention: PP1M->PP1M
Number of subjects: 4609
Study 30058979 — intervention group
Group type: EXPERIMENTAL
Intervention: PP1M->PP3M
Number of subjects: 4609
Study 30058979 — intervention group
Group type: COMPARATOR
Intervention: OA
Number of subjects: 4609
Study 26860434 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based walking program (Walkadoo) with a free wireless activity tracker, duration 6 weeks.
Number of subjects: 265
Study 26860434 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group), duration 6 weeks.
Number of subjects: 265
Study 24692480 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal‐directed fluid therapy (EGDT) guided by preload volume and cardiac output monitored by transpulmonary thermodilution
Number of subjects: 160
Study 24692480 — intervention group
Group type: COMPARATOR
Intervention: Standard less‐invasive hemodynamic therapy guided by fluid balance or central venous pressure
Number of subjects: 160
Study 23155313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraderal route (ID) with recombinant hepatitis B vaccine (Engerix B) 2 μg
Number of subjects: 58
Study 23155313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular route (IM) with recombinant hepatitis B vaccine (Engerix B) 10 μg
Number of subjects: 58
Study 19330600 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 12.5 mg/day (T + H, n = 32)
Number of subjects: 64
Study 19330600 — intervention group
Group type: COMPARATOR
Intervention: No change in current drug regimen (CTL, n = 32)
Number of subjects: 64
Study 17890789 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild diuretic treatment in addition to standard treatment for acute COPD exacerbation (group 1A)
Number of subjects: 30
Study 17890789 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment for acute COPD exacerbation (group 1B)
Number of subjects: 30
Study 17890789 — intervention group
Group type: COMPARATOR
Intervention: Stable COPD (group 2 control)
Number of subjects: 30
Study 15538121 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 0
Study 15538121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11782726 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to clinical information from a computer-based patient record system
Number of subjects: 2
Study 11782726 — intervention group
Group type: COMPARATOR
Intervention: No access to clinical information from a computer-based patient record system
Number of subjects: 2
Study 9025743 — intervention group
Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 180 microCi/kg (6.66 MBq/kg)
Number of subjects: 17
Study 9025743 — intervention group
Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 229 microCi/kg (8.47 MBq/kg)
Number of subjects: 17
Study 9025743 — intervention group
Group type: EXPERIMENTAL
Intervention: 117mSn(4+)DTPA at 285 microCi/kg (10.55 MBq/kg)
Number of subjects: 17
Study 8200888 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical capacitive coupling treatment
Number of subjects: 23
Study 8200888 — intervention group
Group type: COMPARATOR
Intervention: Placebo unit
Number of subjects: 23
Study 3310476 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous vein grafting
Number of subjects: 0
Study 3310476 — intervention group
Group type: COMPARATOR
Intervention: Direct suturing
Number of subjects: 0
Study 28131433 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 70
Study 28131433 — intervention group
Group type: COMPARATOR
Intervention: Attention control class
Number of subjects: 70
Study 28395507 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (n=20)
Number of subjects: 40
Study 28395507 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (n=20)
Number of subjects: 40
Study 28395507 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 40
Study 26627878 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated blood pressure (systolic ≥140 and/or diastolic ≥90 mm Hg) at any point during the trial
Number of subjects: 18201
Study 26627878 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated blood pressure at any point during the trial
Number of subjects: 18201
Study 26627878 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 18201
Study 26627878 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated blood pressure at study entry
Number of subjects: 18201
Study 23642476 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed protein formula (eHPF)
Number of subjects: 0
Study 23642476 — intervention group
Group type: COMPARATOR
Intervention: Standard preterm formula (SPF)
Number of subjects: 0
Study 21903571 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 32
Study 21903571 — intervention group
Group type: COMPARATOR
Intervention: Secondary wound closure
Number of subjects: 32
Study 18362603 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day ambulatory continuous femoral nerve block with perineural ropivacaine 0.2%
Number of subjects: 50
Study 18362603 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 50
Study 17138191 — intervention group
Group type: EXPERIMENTAL
Intervention: B-C-M (bupivacaine-clonidine-midazolam mixture)
Number of subjects: 110
Study 17138191 — intervention group
Group type: COMPARATOR
Intervention: B-C (bupivacaine-clonidine mixture)
Number of subjects: 110
Study 12683477 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated cognitive‐behavioral insomnia therapy (ACBT)
Number of subjects: 20
Study 12683477 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene recommendations (SHC)
Number of subjects: 20
Study 10919417 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.2% concentration
Number of subjects: 48
Study 10919417 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane at 1.5% concentration
Number of subjects: 48
Study 10919417 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane at 2% concentration
Number of subjects: 48
Study 10919417 — intervention group
Group type: COMPARATOR
Intervention: Positive suggestion
Number of subjects: 48
Study 10919417 — intervention group
Group type: COMPARATOR
Intervention: Neutral suggestion
Number of subjects: 48
Study 10919417 — intervention group
Group type: COMPARATOR
Intervention: Bispectral index
Number of subjects: 48
Study 8875723 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month chemotherapy (streptomycin, rifampicin, isoniazid)
Number of subjects: 114
Study 8875723 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month chemotherapy (streptomycin, rifampicin, isoniazid)
Number of subjects: 114
Study 8875723 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month chemotherapy (streptomycin, sodium para-aminosalicylic acid, isoniazid)
Number of subjects: 114
Study 8875723 — intervention group
Group type: EXPERIMENTAL
Intervention: All chemotherapy regimens (6-month, 9-month, 18-month)
Number of subjects: 114
Study 7933184 — intervention group
Group type: COMPARATOR
Intervention: Maximal electrical sphincter stimulation (4 times 30 minutes)
Number of subjects: 13
Study 7933184 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal electrical sphincter stimulation (30 minutes twice daily for 12 days)
Number of subjects: 13
Study 7933184 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal electrical sphincter stimulation
Number of subjects: 13
Study 2853406 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 46
Study 2853406 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 46
Study 2853406 — intervention group
Group type: COMPARATOR
Intervention: Diuretic and placebo (combined control group)
Number of subjects: 46
Study 29609554 — intervention group
Group type: EXPERIMENTAL
Intervention: MyCourse - Moderate Drinking (intervention for alcohol moderation)
Number of subjects: 0
Study 29609554 — intervention group
Group type: EXPERIMENTAL
Intervention: MyCourse - Quit Smoking (intervention for smoking cessation)
Number of subjects: 0
Study 29609554 — intervention group
Group type: COMPARATOR
Intervention: Online static information brochure on alcohol (control for AM RCT)
Number of subjects: 0
Study 29609554 — intervention group
Group type: COMPARATOR
Intervention: Online static information brochure on smoking (control for SC RCT)
Number of subjects: 0
Study 28043937 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg, once daily)
Number of subjects: 407
Study 28043937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study 28043937 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 407
Study 25151552 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet Eye Training (QET)
Number of subjects: 20
Study 25151552 — intervention group
Group type: COMPARATOR
Intervention: Traditional Technical Training (TT)
Number of subjects: 20
Study 22130488 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin followed by idrabiotaparinux (5-10 days' enoxaparin 1.0 mg/kg twice daily followed by subcutaneous idrabiotaparinux starting dose 3.0 mg)
Number of subjects: 3202
Study 22130488 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin plus warfarin (adjusted-dose warfarin with target INR 2.0-3.0)
Number of subjects: 3202
Study 19692375 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-combination latanoprost/timolol
Number of subjects: 854
Study 19692375 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 854
Study 19692375 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 854
Study 18478934 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Shenqi-fuzheng injection
Number of subjects: 232
Study 18478934 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 232
Study 16335682 — intervention group
Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) for 5 years
Number of subjects: 72
Study 16335682 — intervention group
Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) started before age 15
Number of subjects: 72
Study 16335682 — intervention group
Group type: EXPERIMENTAL
Intervention: EP treatment with 2mg of estradiol (E2) started after age 20
Number of subjects: 72
Study 16335682 — intervention group
Group type: COMPARATOR
Intervention: Patients with TS
Number of subjects: 72
Study 12016345 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse Muscle Coactivation (DMC) in persons with fibromyalgia
Number of subjects: 0
Study 12016345 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9685472 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute videotape about polio vaccination and choices of schedules
Number of subjects: 287
Study 9685472 — intervention group
Group type: COMPARATOR
Intervention: Vaccine Information Statement (VIS) only
Number of subjects: 287
Study 8062601 — intervention group
Group type: EXPERIMENTAL
Intervention: 50/50 insulin mixture
Number of subjects: 18
Study 8062601 — intervention group
Group type: COMPARATOR
Intervention: 70/30 insulin mixture
Number of subjects: 18
Study 3055895 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium-DTPA-enhanced T1-weighted spin-echo
Number of subjects: 20
Study 3055895 — intervention group
Group type: EXPERIMENTAL
Intervention: Unenhanced STIR scans
Number of subjects: 20
Study 3055895 — intervention group
Group type: EXPERIMENTAL
Intervention: STIR sequences
Number of subjects: 20
Study 3055895 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined approach using T1-weighted spin-echo, Gd-DTPA-enhanced T1-weighted spin-echo, and STIR images
Number of subjects: 20
Study 3055895 — intervention group
Group type: COMPARATOR
Intervention: T2-weighted spin-echo images
Number of subjects: 20
Study 30054099 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-visit treatment
Number of subjects: 150
Study 30054099 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX) group (2-visit treatment)
Number of subjects: 150
Study 30054099 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide group (2-visit treatment)
Number of subjects: 150
Study 29146633 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of antibiotics (including an option for complete outpatient therapy)
Number of subjects: 1552
Study 29146633 — intervention group
Group type: COMPARATOR
Intervention: Appendectomy
Number of subjects: 1552
Study 29146633 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of antibiotics
Number of subjects: 1552
Study 26396054 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g of daily walnut intake for 4 weeks
Number of subjects: 38
Study 26396054 — intervention group
Group type: COMPARATOR
Intervention: 5 g of daily walnut intake for 4 weeks
Number of subjects: 38
Study 23237981 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-wheeled walker
Number of subjects: 27
Study 23237981 — intervention group
Group type: EXPERIMENTAL
Intervention: U-Step walker
Number of subjects: 27
Study 23237981 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-wheeled walker
Number of subjects: 27
Study 23237981 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard walker
Number of subjects: 27
Study 23237981 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser light use on U-Step walker
Number of subjects: 27
Study 23237981 — intervention group
Group type: COMPARATOR
Intervention: All devices except four-wheeled and U-Step walkers
Number of subjects: 27
Study 22035826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity whole-body endurance-and-strength program
Number of subjects: 40
Study 22035826 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity calisthenics-and-breathing-exercises program
Number of subjects: 40
Study 18471953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (US)
Number of subjects: 200
Study 18471953 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy (Laser)
Number of subjects: 200
Study 17071205 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium (3 g/d) and vitamin D (1 g/d) for 2 weeks
Number of subjects: 90
Study 17071205 — intervention group
Group type: COMPARATOR
Intervention: No supplement (control group)
Number of subjects: 90
Study 15024770 — intervention group
Group type: EXPERIMENTAL
Intervention: Variwall nailing
Number of subjects: 44
Study 15024770 — intervention group
Group type: COMPARATOR
Intervention: Kuntscher nailing
Number of subjects: 44
Study 11095326 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 40 mg/day (N = 90)
Number of subjects: 235
Study 11095326 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 30 mg/day (N = 89)
Number of subjects: 235
Study 11095326 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 36)
Number of subjects: 235
Study 11095326 — intervention group
Group type: COMPARATOR
Intervention: Placebo with aspirin 650 mg q.i.d. for the last 7 days (N = 20)
Number of subjects: 235
Study 9366932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg bolus followed by 2 micrograms/kg/min infusion for 24 hours, then 1 microgram/kg/min for 48 hours)
Number of subjects: 20
Study 9366932 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 20
Study 9366932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1564126 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap sodium 120 mg daily for 28 days
Number of subjects: 12
Study 1564126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1564126 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap sodium 120 mg daily
Number of subjects: 12
Study 4073452 — intervention group
Group type: EXPERIMENTAL
Intervention: Amethocaine spinal anaesthesia (SAB)
Number of subjects: 17
Study 4073452 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide‐halothane general anaesthesia (GA)
Number of subjects: 17
Study 31702560 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based test for measuring refractive error
Number of subjects: 100
Study 31702560 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based test for uncorrected visual acuity
Number of subjects: 100
Study 31702560 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based test for corrected visual acuity
Number of subjects: 100
Study 31702560 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based test for participants with mild myopia (<3 D)
Number of subjects: 100
Study 30400340 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate from bananas (BAN)
Number of subjects: 20
Study 30400340 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate from a 6% sugar beverage (SUG)
Number of subjects: 20
Study 30400340 — intervention group
Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 20
Study 27136251 — intervention group
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) administered at baseline, 2, 6, and 12 months after transplant; 12-month PSQI categorized good versus poor sleepers.
Number of subjects: 75
Study 27136251 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender as a predictor of poor sleep quality.
Number of subjects: 75
Study 27136251 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between poor sleep quality and mental HRQOL.
Number of subjects: 75
Study 24931322 — intervention group
Group type: EXPERIMENTAL
Intervention: Vatreptacog alfa (80 μg kg(‐1), one to three doses)
Number of subjects: 72
Study 24931322 — intervention group
Group type: COMPARATOR
Intervention: rFVIIa (90 μg kg(‐1), one to three doses)
Number of subjects: 72
Study 24931322 — intervention group
Group type: EXPERIMENTAL
Intervention: Vatreptacog alfa
Number of subjects: 72
Study 21625881 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 85
Study 21625881 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 85
Study 20449645 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge-based measure of social information processing and anger management techniques
Number of subjects: 0
Study 18630772 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 microg/kg nitroglycerine
Number of subjects: 150
Study 18630772 — intervention group
Group type: COMPARATOR
Intervention: No drug (Control)
Number of subjects: 150
Study 16202020 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of dental clinical practice guideline with multifaceted interventions (feedback, reminders, interactive meeting)
Number of subjects: 0
Study 16202020 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 12021826 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 0
Study 12021826 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 12021826 — intervention group
Group type: EXPERIMENTAL
Intervention: IV Diazepam
Number of subjects: 0